Type 1 diabetes mellitus and its oral tolerance therapy

doi:10.4239/wjd.v11.i10.400

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7292)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

449

WORD

176

HTML

3265

Figures (1-2)

359

Sum=4249

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

423

Download

719

Sum=1142

Publishing Process of This Article

Item

Count

Browse

607

Download

1294

Sum=1901

Oct 15, 2020 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Oct 15, 2020; 11(10): 400-415
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.400

Full Size Figure Download Figure

Figure 2 Schematic overview of the stepwise mechanisms of oral tolerance induction. DCs: Dendritic cells; M cell: Microfold cell; CCR: CC-chemokine receptor; pDCs: Plasmacytoid DCs; IDO: Indoleamine 2,3-dioxygenase; RA: Retinoic acid; TGF-β: Transforming growth factor-beta.

Citation: Mao RF, Chen YY, Zhang J, Chang X, Wang YF. Type 1 diabetes mellitus and its oral tolerance therapy. World J Diabetes 2020; 11(10): 400-415
URL: https://www.wjgnet.com/1948-9358/full/v11/i10/400.htm
DOI: https://dx.doi.org/10.4239/wjd.v11.i10.400